Nasal Polyposis Treatment IndustryAccording to a recently released study by Future Market Insights, the global nasal polyposis treatment industry size is anticipated to reach US$ 4.6 billion in value by 2023-end and is likely to grow at a CAGR of 6.7% until 2033. A market valuation of US$ 8.8 billion is anticipated.
Roche has come under pressure to improve its pipeline with medicines it can commercialize soon as a windfall of revenue from products used in the COVID-19 pandemic comes to an end.
Roche Holding AG will pay $7.1 billion to acquire Telavant Holdings Inc., a developer of a promising therapy for treating inflammatory bowel disease, in a bid to shore up its pipeline of experimental medicines.
Roche to buy bowel drugmaker Telavant for $7 1 billion spokesman.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spokesman.com Daily Mail and Mail on Sunday newspapers.
Sanofi to Pay Teva as Much as $1 5 Billion for Bowel Medicine bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.